Biotech firm CEO pleads guilty to Covid-19 securities fraud scheme : vimarsana.com

Keith Berman, CEO and director of Decision Diagnostics Corp (DECN), a public medical device company, has pleaded guilty to securities fraud and wire fraud in connection with his scheme to defraud investors by making false and misleading ...

Related Keywords

Washington , United States , Keith Berman , Us Department Of Justice , Decision Diagnostics Corp , Drug Administration ,